Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) has posted results for the last fiscal year, recording EPS of $-1.85. For this year, EPS is anticipated to grow -12.40% over the preceding year, while next year’s EPS is predicted to increase -5.60%.
The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction. Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.
Shares of Ekso Bionics Holdings, Inc. are now trading at $1.81, giving it market cap of $45.63M. Over the last 12 months, shares of Ekso Bionics Holdings, Inc. have risen to maximum of $-73.35% and declined to a minimum of $82.83%.
The stock’s beta, which measures volatility, is 1.59. For the purpose of clarity, note that a beta of less than 1 implies that a stock is less volatile versus the overall market, while a beta over 1 indicates a stock is more volatile over the market.
Ekso Bionics Holdings, Inc. shows 20-Day Simple Moving Average of $39.39% and 50-Day Simple Moving Average of $-17.80%. The 200-Day SMA is $-50.87%.
The stock’s weekly performance is 54.70% while its monthly performance is -7.18%. Year-to-date the equity has moved -54.52% compared to a performance of -65.36% over the preceding 12 months.
Ekso Bionics Holdings, Inc. has witnessed – insider transactions, showing insider ownership of -. That compares to 4.30% ownership by institutional investors after 5.76% institutional transactions.
Return on investments in Ekso Bionics Holdings, Inc. for the last 12 months is -205.90%, while return on assets for the equivalent period is -184.80%. Return on equity for the previous 12 months, on the other hand, is -946.40%.
Ekso Bionics Holdings, Inc. has RSI (Relative Strength Index) of 56.97.